Loading company details...
Latest Form 4 (Oct 1, 2026): Nello Mainolfi (Chief Executive Officer): Exercise/Conversion of 30,000 shares, $62.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Nello Mainolfi, Chief Executive Officer | Exercise/Conversion | 30,000 | $62.4K |
| Sep 4, 2026 | Brian Adams, Chief Legal Officer | Sale | 1,209 | $139.7K |
| Jul 27, 2026 | Terence Rooney, Chief Medical Officer | Grant/Award | 38,000 | n/a |
| Jul 8, 2026 | Nello Mainolfi, Chief Executive Officer | Exercise/Conversion | 50,000 | $104.0K |
| Jul 2, 2026 | Bruce N. Jacobs, Chief Financial Officer | Exercise/Conversion | 61,378 | $327.1K |
| Jul 2, 2026 | Noah Goodman, Chief Business Officer | Sale | 3,389 | $387.3K |
| Jul 2, 2026 | Nello Mainolfi, Chief Executive Officer | Exercise/Conversion | 80,000 | $166.4K |
| Jul 2, 2026 | Bruce Booth | Sale | 5,549 | $587.0K |
| Jun 30, 2026 | Bruce Booth | Sale | 28,296 | $3.04M |
| Jun 26, 2026 | BVF PARTNERS L P/IL | Sale | 837,914 | $89.24M |